Serum Institute of India Pvt. Ltd.
UkraineAll drugs from this manufacturer
-
The vaccine is used for the active immunization of infants and children aged 6 weeks to 2 years for the prevention of pneumonia, acute otitis media, and other invasive diseases caused by pneumococcus.
Dosage form: suspension for injection
Active substance Dosage pneumococcal polysaccharides conjugated to crm197 protein carrier 2 mcg (serotypes 1, 5, 6A, 7F, 9V, 14, 19A, 19F, 23F) or 4 mcg (serotype 6B) ATC: J07AL02